Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ahmad Moolla

BSc (Hons), MBBS (Hons) MEd MRCP


Novo Nordisk Clinical Research Training Fellow (2016-2019)

  • Project: Using Multi-Parametric Magnetic Resonance Techniques to determine the severity and response to treatment of liver fibrosis, inflammation, steatosis and iron in patients with type 2 diabetes and non-alcoholic fatty liver disease

Ahmad was awarded a Novo Nordisk Clinical Research Training Fellowship focused on non-alcoholic fatty liver disease (NAFLD), which is becoming the most common cause of chronic liver disease worldwide and affects up to 70% of patients with type 2 diabetes. He established a clinical trial to investigate the utility of GLP-1 agonists as novel therapeutic agents for patients with NAFLD. Additionally, through this and related clinical studies, he also investigated the use of various biomarkers as novel non-invasive diagnostic tools with which to diagnose and stage NAFLD and to access treatment response.

 Ahmad returned to his clinical career full time in February 2019, whilst writing his DPhil thesis. He is currently a Specialist Registrar in Diabetes, Endocrinology and Metabolism working in the Imperial College North-West Thames NHS Deanery Rotation. He is continuing to develop his sub-specialty interest in obesity and fatty liver disease. He will be completing his post-graduate clinical training during which time he will work on progressing to the next stage of his joint academic and clinical career.